Home Services Commercial Partership Work with us Contact us SERVICES Pharmacy services Docvadis® Care and Care Regions Correct information, medical updating, cultural promotion have always been a hallmark of MSD. Attentive to the needs of doctors and patients, over the years we have developed publications and services with high added value. We support projects aimed at improving information and specialization in the medical-scientific field, helping to keep healthcare professionals constantly informed about scientific progress. At the same time, we support educational programs, at university and post-graduate level through the provision of scholarships and the financing of specialization courses. Ours is a story that starts long ago with the publication, in 1899, of the firstMSD Diagnosis and Therapy Manual , one of the reference texts of internal medicine, translated into 20 languages and constantly updated. Our services are aimed at all players in the health system, from patients to doctors, nurses and pharmacists and aim to meet the needs of updating, training and information and disease management. Financial info Actions Annual report The MSD Manuals Italian edition American Edition Handbook of Geriatrics Pressroom Releases Contacts Our publications Publications Talk Copyright © 2018 MSD Italia Srl All rights reserved. VAT number 00887261006 CORP-1187907-0000-MSD-W-07/2018 Privacy Terms and conditions

Home Services Commercial Partership Work with us Contact us THERAPEUTIC AREAS Anesthesia Asthma and allergic rhinitis Cardiometabolic Dermatology Migraine Hepatitis C HIV / AIDS Immunology Bacterial and fungal infections Oncology Women's health Vaccines Italy is the European country with the highest incidence of hepatitis C virus, with at least one and a half million people affected, but the treatment landscape is destined to change radically in the coming years also thanks to the innovative molecules in development in our laboratories, closer to the needs of the sick and their families. A promise of healing for many patients that has solid roots in our past. For the past 30 years, MSD has been at the forefront of research into Hepatitis C drugs: the first interferon, the first pegylated interferon and the first protease inhibitor. Today this commitment to research is leading us towards an important new therapeutic opportunity to improve the treatment paradigm of Hepatitis C, A 360 ° innovation that also takes the form of digital and multimedia projects capable of making doctors and patients dialogue, as well as providing a timely scientific update. To guarantee the quality of our services, the scientific representatives of this line have obtained the prestigious certification of SIMIT, the Italian Society of Infectious and Tropical Diseases. Information Products Sites for healthcare professionals Virovip Financial info Actions Annual report The MSD Manuals Italian edition American Edition Handbook of Geriatrics Pressroom Releases Contacts Our publications Publications Talk Copyright © 2018 MSD Italia Srl All rights reserved. VAT number 00887261006 CORP-1187907-0000-MSD-W-07/2018 Privacy Terms and conditions